(January 21, 2021, 1:25 PM EST) -- Health care company McLaren Health Care Corp. will pay $7.75 million to resolve a federal investigation that two of its former retail pharmacies violated the Controlled Substances Act by failing to properly account for Schedule II drugs, according to Jan. 19 announcements by two U.S. attorneys and McLaren....